W innych przeprowadzonych badaniach klinicznych wyniki potwierdziy korzystny wpyw peptydu Semaglutide na obnienie poziomu glukozy we krwi, stymulacj wydzielania insuliny przez trzustk, lepsz kontrol glikemii oraz zdrow regulacj wagi u uczestnikw
In fact, in a recent study published in The New England Journal of Medicine, participants who took Semaglutide lost an average of 15% of their body weight over a period of 68 weeks
Pay attention to protein
Some semaglutide patients experience mild muscle cramping, fatigue, or headaches in the first 12 weeks, often linked to electrolyte shifts rather than the medication itself
Complete absence of any effect after two months of use warrants serious investigation
As the manufacturer of an innovative new drug, Novo Nordisk also enjoys data exclusivity for its clinical and manufacturing data through Canadas Food and Drug Regulations until January 4, 2026